NP / PA
Cestaro, Anthony
Cestaro, Anthony was paid $88K by Medicaid between Jun 2019 and Apr 2023, across 8 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 35% of everything it billed.
33Billing provider infoCESTARO, ANTHONY
MIDDLETOWN, NY 10941
MIDDLETOWN, NY 10941
33aNPI1346693546assigned 07/22/2016
33bProvider typePhysician Assistant
28Total paid$88K
24GClaims780
24DCodes billed8
24AFirst – last monthJun 2019 – Apr 2023
Compared with peers
Next to other Physician Assistant providers in New York
Rank by total paid#35 of 263
Median peer was paid$3K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 15 | $1K | |
| 2020 | 150 | $17K | |
| 2021 | 162 | $21K | |
| 2022 | 377 | $42K | |
| 2023 | 76 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 35% | 223 | 223 | $30K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 292 | 283 | $28K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 90 | 90 | $11K |
| S9083 | Global fee urgent care centers | 12% | 69 | 69 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.4% | 63 | 63 | $6K |
| 87634 | <1% | 12 | 12 | $842.40 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 14 | 13 | $491.26 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 17 | 17 | $388.75 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.